Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001062993-14-004598
Filing Date
2014-08-06
Accepted
2014-08-06 17:26:49
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM POS AM posam.htm POS AM 1366219
2 EXHIBIT 23.1 exhibit23-1.htm EX-23.1 1207
3 EXHIBIT 23.2 exhibit23-2.htm EX-23.2 1193
10 GRAPHIC forms1ax4x1.jpg GRAPHIC 3287
11 GRAPHIC bdo.gif GRAPHIC 1373
  Complete submission text file 0001062993-14-004598.txt   14808627

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE avxl-20140331.xml EX-101.INS 1267704
5 XBRL SCHEMA FILE avxl-20140331.xsd EX-101.SCH 442149
6 XBRL CALCULATION FILE avxl-20140331_cal.xml EX-101.CAL 49597
7 XBRL DEFINITION FILE avxl-20140331_def.xml EX-101.DEF 1015217
8 XBRL LABEL FILE avxl-20140331_lab.xml EX-101.LAB 2932220
9 XBRL PRESENTATION FILE avxl-20140331_pre.xml EX-101.PRE 1121491
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: POS AM | Act: 33 | File No.: 333-191682 | Film No.: 141020988
SIC: 8731 Services-Commercial Physical & Biological Research